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Abstract: Introduction: Chronic bronchitis (CB) is a multifactorial disease with a complex number 
of internal and external etiological risk factors. One of the main risk factors for the development of 
CB in adolescents and chronic obstructive pulmonary disease (COPD) in adults is tobacco smoking. 
It is also known that an important internal risk factor for the development of СB is a genetic 
predisposition.   
Methods: We examined 40 adolescent smokers with CB, 30 never-smoker adolescents with CB, and 
37 healthy adolescent smokers (control group). Each patient’s history was collected along with 
findings from an objective examination. Molecular genetic investigations were conducted on 30 
adolescent smokers with CB and 30 healthy adolescent smokers. Calculation of the smoking index 
and the packs/year were made.  
Results: Smoking leads to the development of CB as early as adolescence and affects its course, 
increasing the frequency and duration of bronchitis attacks. We identified an association of the 
2G/2G genotype of MMP1 gene with the development of CB in adolescent smokers. The TT 
genotype of CYP1A1 gene may be considered as a possible sustainability factor for the 
development of CB in adolescent smokers. 
Conclusions: The study of candidate genes for COPD in childhood and adolescence will facilitate 
the early detection of high-risk groups in the formation of this pathology, which will allow doctors 
to take the necessary preventive measures.  
 
Key words: chronic bronchitis, COPD, tobacco smoking, adolescents. 
 
INTRODUCTION Chronic bronchitis (СB) in children 
and adolescents is a pressing problem in childhood 
pulmonology [1-3]. CB is a multifactorial disease with a 
complex etiology, involving a number of internal and 
external risk factors [4]. Tobacco-smoking is one of the 
main risk factors for the development of CB in 
adolescents and chronic obstructive pulmonary disease 
(COPD) in adults [5,6]. COPD is a leading cause of 
morbidity and mortality worldwide that includes 
substantial and increasing economic and social burdens. 
COPD is currently the fourth leading cause of death in 
the world but is projected to advance to the 3rd leading 
cause of death by 2020. More than 3 million people died 
of COPD in 2012, accounting for 6% of all deaths globally 
[6]. 
Environmental exposures in childhood are important 
to the pathogenesis of COPD. Attenuation of lung 
growth due to air pollution in childhood is a risk factor 
for adult-onset respiratory disease. Common 
pulmonary cellular and molecular mechanisms 
underlying impaired innate host defenses in children 
exposed to air pollution and susceptibility to infection 
result in lung damage initiated in childhood that 
contributes to the global COPD health issue that is 
further exacerbated by exposure to tobacco smoke 
[7].  
 
The clinical manifestations and the course of diseases 
of the broncho-pulmonary system are determined not 
only by the duration of harmful factors, but also by the 
individual characteristics of the person [8]. Therefore, 
genetic predisposition with regard to immunological 
reactivity and growth and development of the lungs 
are closely linked [8]. Today, the genetic mechanisms 
responsible for the formation of COPD in adults have 
become the object of large-scale research around the 
world [9-11], but in childhood, the genetic risk factors 
for chronic respiratory diseases, except for bronchial  
*Corresponding author: S. Ilchenko,  
9, Vernadsky St.,Dnipro, 49044, Ukraine;  
e-mail: Ilchensv@gmail.com 
phone +38 (050) 453-48-16 
 
S. Ilchenko, A. Fialkovska© 
 
 
5 
 
 
  
International Journal of Integrative Pediatrics and Environmental Medicine, V 4, 2019, 4-9  
asthma and cystic fibrosis, have been largely ignored. 
Thus, the study of the role of tobacco smoking in the 
development of CB in children and adolescents with 
analysis of molecular genetic factors can provide 
additional information on the mechanisms of disease 
formation and will allow us to predict these conditions 
and develop methods for disease prevention. 
 
The purpose of the study is to investigate the clinical 
features of the course of CB in adolescent smokers and 
to study the genetic risk factors for the development 
of COPD. 
 
METHODS We examined 107 adolescents. Patients 
were divided into three groups. Group 1 consisted of 
40 adolescent smokers with chronic bronchitis (mean 
age 17.5±0.2 years). Group 2 consisted of 30 never-
smokers adolescents with chronic bronchitis (mean 
age 16.0±0.4 years). Group 3 (control group) consisted 
of 37 healthy adolescents-smokers (average age 
16.3±0.3 years). Diagnoses were verified based on 
standard criteria (laboratory-clinical and instrumental 
examination).  
 
The study included each patient's account of his/her 
medical history and an objective examination. The 
status of smoking among adolescent smokers has 
been examined as a risk factor for the development of 
the disease with the calculation of the smoking index 
(SI), which was defined as the number of cigarettes 
smoked per day multiplied by years smoked. The 
indicator, pack/year, was also calculated as the 
number of cigarettes smoked per day/20 × number of 
years smoked. 
 
To achieve our aim to study the genetic risk factors for 
the development of COPD, the MMP1 gene ‐1607 
1G/2G (rs1799750) polymorphism and CYP1A1 gene 
T3801C polymorphism were studied. Molecular 
genetic investigations were performed at the Institute 
 
of Hereditary Pathology, Academy of Medical Sciences  
of Ukraine. The study material was DNA isolated from 
the peripheral blood leukocytes of 30 patients 
randomly selected from Group 1 and 30 patients 
randomly selected from Group 3. DNA was isolated 
from leukocytes and purified, using the kits for the 
GenePak DNA polymerase chain reaction (PCR) test 
(IzoGen Laboratory, Russia). The DNA sequences were 
amplified in vitro, using the PCR method and the 
restriction fragment length polymorphism method. 
The PCR was performed under an automatic regimen 
in a Tercik thermocycler (DNA Technology, Russia), 
using oligonucleotide primers (Fermentas, Lithuania), 
specific restriction endonucleases, and the GenPak 
PCR Core kits of agents for amplification (IzoGen 
Laboratory, Russia). The restriction fragments were 
analyzed and the specificity of PCR products were 
electrophoretically determined. 
 
All statistical calculations were performed using 
Statistica v 10.0. Results were presented as means ± 
standard deviation (SD), medians, and interquartile 
range (Q25; Q75). Each of the single nucleotide 
polymorphisms (SNPs) in genes of interest was 
analyzed for Hardy-Weinberg equilibrium using a 
computer program for analyzing genetic data 
(GeneExpert, http://gen-exp.ru/calculator_or.php). 
To determine the SNPs associated with the risk of  
CB, the frequencies of the genotypes of the two study 
groups were compared, and the odds ratio (OR) was 
calculated with a 95% confidence interval (CI). 
Statistical significance was defined as p<0.05. 
 
RESULTS The analysis of the tobacco smoking status 
(Table 1) showed that patients in Group 1 began 
smoking at the same age as the adolescent smoking 
controls (Group 3), but smoked significantly more 
cigarettes per day, had significantly higher values of SI, 
and smoked more packs/year than the Group 3. Group 
1 had also smoked more years, but the mean age in 
 Group 1 (n=40) Control 3 (n=37) р 
Age of the beginning of smoking, years 
14.0 
(12.0; 14.0) 
14.0 
(13.0; 15.0) 
р>0.05 
 
Years of active tobacco smoking 
4.0 
(3.0; 5.5) 
2.0 
(1.0; 2.0) 
р<0.05 
 
Number of cigarettes smoked per day 
10.0 
(10.0; 13.5) 
7.0 
(5.0; 10.0) 
р<0.05 
 
Smoking index 
120.0 
(120.0; 162.0) 
84.0 
(60.0; 120.0) 
р<0.05 
 
packs/year 
2.0 
(1.5; 3.25) 
0.5 
(0.25; 1.0) 
р<0.05 
 
Table 1. Indicators of the tobacco smoking status in adolescent smokers, Medians (Q25; Q75) 
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the group was also older. 
 
A comparison of the clinical features of bronchitis 
showed that patients in Group 2 had bronchitis longer 
than those in Group 1 (6.9 ± 0.8 vs. 3.2 ± 0.2 years, 
respectively; р<0.05) (Figure 1). The number of 
bronchitis attacks per year among patients in Group 1 
and Group 2 were similar (3.9±0.1 vs. 3.9±0.3; p>0.05), 
but patients in Group 1 experienced longer durations 
of the attacks than patients in the non-smoking Group  
2 (4.1 ± 0.1 weeks versus 3.6 ± 0.1 weeks; p <0.05). 
 
Among the adolescent smokers of Group 1, the 
durations of the attacks differed, but the frequency of 
attacks correlated with the number of smoked  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
cigarettes per day (r=+0.56; p<0.05), SI (r=+0.56; 
p<0.05) and the pack-year (r=+0.59; p<0.05). 
 
Analysis of clinical data showed that the course of CB 
in adolescent smokers in the period of clinical 
remission was characterized by complaints of 
permanent (65.0% vs 12.5%; p<0.05) low-productive 
cough (95.0% vs 18.7%; p<0.001) predominantly in the 
mornings (90.0% vs 25.0%; p<0.001). Bronchitis 
attacks in patients of Group 1 compared to Group 2, 
were characterized by the absence of seasonality 
(90.0% vs 25.0%; p<0.001), complaints of low-
productive cough (80.0% vs 31.2%; p<0.01) with 
predominantly mucosal sputum (85.0% vs 25.0%;  
 
 
Figure 1. Clinical and anamnestic features of the course of chronic bronchitis in the examined 
adolescents 
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Figure 2. Genotype frequencies of MMP1 gene ‐1607 1G/2G (rs1799750) polymorphism in the studied 
groups. 
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p<0.001), dyspnea during exercise (60.0% vs 25.0%;  
p<0.05), and prevalence during auscultation of dry 
wheezing (70.0% vs 6.3%; p<0.05). In Group 2, more 
patients were likely to exhibit moist rales (56.2% 
versus 20.0%; p<0.05) and mixed rales (37.5% vs 
10.0%; p<0.05) at auscultation. 
 
The results of the molecular genetic study revealed a 
statistically significant difference between Group 1 
and Group 3 (Figure 2). When comparing the 
frequencies of the genotypes of the MMP1 gene ‐1607 
1G/2G (rs1799750) polymorphism.  
 
In patients of Group 1 compared with Group 3, the 
frequency of the homozygous genotype 2G/2G was 
significantly higher (66.7% vs 6.7%; OR=28.00; 95% СІ 
[2.82-277.97]). In the control group, the heterozygous 
genotype 1G/2G was more common (73.3% vs 33.3%; 
OR=0.18; 95% CІ [0.04-0.87]). 
 
The analysis of the frequency distribution of 
genotypes of the CYP1A1 gene showed a significant 
increase in the proportion of homozygous TT carriers 
in the control group compared to Group 1 (93.3% vs 
53.3%, χ2=6.21; р<0.05) (Figure 3). 
 
Thus, the molecular genetic study revealed the 
association of the 2G/2G genotype of MMP1 gene ‐
1607 1G/2G (rs1799750) polymorphism (OR=28.00; 
95% CI [2.82-277.97]) with the development of 
chronic bronchitis in adolescent smokers. The TT 
genotype of CYP1A1 gene T3801C polymorphism 
(OR=0.08; 95 % CI [0.01-0.79]) may be considered as a 
possible sustainability factor for the development of 
chronic bronchitis in adolescent smokers. 
 
DISCUSSION The significance of tobacco use with CB 
in pediatric practice has been the subject of discussion 
for many years. The role of tobacco smoking in the 
development of chronic respiratory pathology is 
widely studied in adults, but rarely in children and  
adolescents. Оur study demonstrated that smoking 
leads to the development of CB in adolescence and 
affects its course, increasing the frequency and 
duration of bronchitis attacks. In addition, we found 
that the frequency of attacks correlates with the 
number of cigarettes smoked per day, SI, and packs 
smoked per year. 
 
Furthermore, we established, that the 2G/2G 
genotype of MMP1 gene ‐1607 1G/2G (rs1799750) 
polymorphism can be considered as a risk factor for 
the development of CB in Ukrainian adolescent 
smokers. The homozygous version of the gene with a 
deletion of guanine 2G is known to have higher 
transcriptional activity than the heterozygous one 
[12].  
 
This causes an increase in the enzymatic activity of 
MMP-1 in lung epithelial cells and disrupts the balance 
in the protease-antiprotease system. MMP-1 
hypersecretion causes destruction of Type III collagen 
and leads to the formation of emphysema [13]. 
 
Enzymes of a xenobiotic biotransformation system 
play an important role in protecting the lungs from 
toxic products that are contained in tobacco smoke 
YP1A1 (Cytochrome P450, family 1, subfamily A, 
polypeptide 1) bioactivates benzopyrene and 
polycyclic aromatic hydrocarbons, two important 
components of tobacco smoke. The T3801C     
 
Figure 3. Genotype frequencies of CYP1A1 gene T3801C polymorphism in the studied groups 
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polymorphism of the CYP1A1 gene causes an amino 
acid replacement of thymine by cytosine, which leads 
to an increase in the enzymatic activity of the enzyme 
and the accumulation of active toxic substances in 
cells, including active oxygen molecules [14].  
 
The active oxygen molecules have high cytotoxicity 
with respect to all cell types and contribute to the 
development of COPD. Damage to fibroblasts, 
reduction in the activity of surfactant, stimulation of 
the formation of thromboxane, increased epithelial 
permeability, and disruption of the function of cilia are 
increased [15]. The absence of mutation determines 
the normal level of synthesis and enzyme activity, 
which protects the lungs from toxic substances that 
are contained in tobacco smoke [16]. Thus, the 
presence of TT genotype of CYP1A1 gene T3801C 
polymorphism in adolescent smokers can be 
considered as a possible marker of resistance to 
chronic diseases of the respiratory system.  
 
We have established that the development of CB in 
adolescents depends not only on the number of 
cigarettes smoked per day, SI, and packs per year, but 
also on the presence of molecular genetic factors.  
 
The study of the genes for COPD in childhood and 
adolescence will contribute to the early detection of 
high-risk patients for the development of this 
pathology, which may make it possible to encourage 
necessary preventive measures and to maximize 
postponement of disease development. 
 
CONCLUSIONS Smoking leads to the development of 
CB as early as adolescence. The 2G/2G genotype of 
MMP1 gene ‐1607 1G/2G (rs1799750) polymorphism 
can be considered as a risk factor for the development 
of CB in Ukrainian adolescent smokers, and the TT 
genotype of CYP1A1 gene T3801C polymorphism in 
adolescent smokers can be considered as a possible 
marker of resistance to CB of the respiratory system. 
The study of candidate genes for COPD in childhood 
and adolescence will facilitate the early detection of 
high-risk groups in development of CB, which will 
allow doctors to take the necessary preventive 
measures. 
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